Project Grant 2042111
Award Date 5/1/21
Completion Date 4/30/23
Dollars Obligated $300K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Minneapolis, MN 55455, USA
Similar Awards
- The Regents of the University of California, San Francisco (UCSF) received a $550,000 Project Grant award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop an advanced cryopreservation system for complex bioengineered tissues. The project aims to determine the thermodynamic and biological parameters needed for isochoric supercooling cryopreservation of three-dimensional tissues within a microgravity-optimized...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $379,997 provides funding to the University of Minnesota Duluth and Fairleigh Dickinson University to enhance their research capacity and develop partnerships with industry and community stakeholders. The key objectives are to: (1) improve communication strategies for external collaborations, (2) establish a sustainable faculty seed grant program, (3) advance industry relations,...
- The National Science Foundation awarded a $249,884 Project Grant to the Regents of the University of Minnesota under the NSF Technology, Innovation, and Partnerships federal grant program (CFDA 47.084) to develop a decentralized, on-demand production system for large volume parenteral solutions and medical fluids. The University will implement a proof-of-concept prototype capable of producing 100 L/hr of solutions such as electrolyte replacement, intravenous fluids, and dialysis mixtures on-site...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $273,388 to Histone Therapeutics, a woman-owned small business, aims to epigenetically modify natural killer (NK) cells to enhance their ability to detect and kill cancer cells. The goal is to develop a broad-spectrum NK cell therapy that can be used in combination with current cancer treatments to improve effectiveness without increasing side effects. The project will assess...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,155,000.00 to the Regents of the University of Minnesota to evaluate prostate cancer patient natural killer cell function across racial backgrounds and address any functional disparities using tri-specific killer engagers. The research project will be conducted from June 1, 2025 through May 31, 2029 in Minneapolis, MN. As a prominent land-grant...
- The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $787,793 Project Grant to the Regents of the University of Minnesota to conduct research on "LEVERAGING TARGETED BIOLOGICAL COMPLEXES TO MAXIMIZE NATURAL KILLER CELL IMMUNOTHERAPY IN LUNG CANCER". The three-year award, running from July 1, 2024 to June 30, 2027, will support the university's efforts to develop innovative immunotherapy approaches for treating lung cancer, with a...
- The Regents of the University of Minnesota received a three-year, $806,000 Project Grant award from the National Science Foundation Division of Biological Infrastructure. The grant supports the "IIBR INFORMATICS: MINING SPATIAL AND SINGLE-CELL TRANSCRIPTOMES TO UNDERSTAND CELL LOCALITY AND HETEROGENEITY IN TISSUES" project under the Biological Sciences program (CFDA #47.074). The project aims to advance understanding of major biological problems by promoting progress in the...
- The National Science Foundation (NSF) Engineering program (CFDA 47.041) has awarded a $650,267 Project Grant to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to identify and characterize low toxicity cryoprotective solutions for cryopreservation. The 5-year award, beginning on July 15, 2025, aims to use high-throughput screening to examine a larger chemical space of glass-forming molecules and discover cryoprotectant formulations with minimal toxicity....
- This federal Project Grant award for $1,059,132.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by the Regents of the University of Minnesota into the targeting of IGF1R and IR-A in hormone receptor-positive breast cancer using natural killer cells. The award period runs from August 1, 2025 to July 31, 2028. As a prominent 1862 land-grant research institution, the University of Minnesota has demonstrated...
- The Regents of the University of Minnesota received a $506,505 Project Grant award from the National Science Foundation Office of Advanced Cyberinfrastructure. The grant is part of the NSF's Computer and Information Science and Engineering program (CFDA 47.070), which supports investigator-initiated research and education in computing, communications, and information science and engineering. Under the award, the University will develop open-source tools for analyzing block polymer phase behavior...